Several researchers put forward an alternative strategy that CAR-T cells engineered to produce extracellular vesicles containing RN7SL1 by delivering the pattern recognition receptor agonists could effectively stimulate anti-tumor immunity 182. The gene discussed is RN7SL1; the disease is neoplasm.